<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03597126</url>
  </required_header>
  <id_info>
    <org_study_id>RoboticISR</org_study_id>
    <nct_id>NCT03597126</nct_id>
  </id_info>
  <brief_title>Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer</brief_title>
  <acronym>R-ISR</acronym>
  <official_title>Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer:A Multicentric Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compared robot-assisted total mesorectal excision to treat very low rectal cancer
      within 2 cm from the dentate line to avoid permanent colostomy. improves the quality of life
      with better defecation function, urinary function and sexual function.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2018</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in urinary function</measure>
    <time_frame>6 months</time_frame>
    <description>The days of indwelling catheter after operation The overall efficiency of urination function</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in International Index of Erectile Function [IIEF] score</measure>
    <time_frame>18 months</time_frame>
    <description>Alterations in IIEF scores from baseline up to 18 months postoperatively - 15 item questionnaire, each item range from 0 - 5, with total score to 30. lower score indicates more severe erectile dysfunction (ED)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in FIQL scores</measure>
    <time_frame>18 months</time_frame>
    <description>Alterations in Fecal Incontinence Quality of Life Instrument (FIQL) scores from baseline up to 18 months postoperatively - 29 items range from 1 (strongly agree) to 4 (strongly disagree); with a 1 indicating a lower functional status of quality of life. Scale scores are only calculated if at least half of the items have been answered</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Female Sexual Function Index [FSFI]</measure>
    <time_frame>18 months</time_frame>
    <description>Alterations in FSFI from baseline up to 18 months postoperatively - 19-item self-report measure, each item ranges from 0-5, with full range from 2 to 36, with low score indicating sexual function disorder.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>robot-assisted ISR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with low rectal cancer undergo intersphincteric resection assisted by Robotic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>laparoscopic ISR</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with low rectal cancer undergo laparosocopic intersphincteric resection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Robot-assisted surgery</intervention_name>
    <description>robot-assisted intersphincteric resection for low location rectal cancer(T=1&amp;2)</description>
    <arm_group_label>robot-assisted ISR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laparoscopic surgery</intervention_name>
    <description>laparoscopic intersphincteric resection for low location rectal cancer(T=1&amp;2)</description>
    <arm_group_label>laparoscopic ISR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 18 years &lt; age &lt; 80 years

          2. Matching the diagnostic criteria;

          3. tumor located 3 cm from anal verge

          4. Clinically diagnosed cT1-3N0-2 M0 lesions

          5. Tumor size of 4 cm or less

          6. ASA 1-3 scores;

          7. ECOG score is 0-1;

          8. Adequate preoperative sphincter function

        Exclusion Criteria:

          1. Requiring a Mile's procedure

          2. Fecal incontinence;

          3. Previous abdominal surgery

          4. Severe mental disease.

          5. Intolerance of surgery for severe comorbidities

          6. Emergency operation due to complication

          7. Pregnant woman or lactating woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tang Bo, M.D</last_name>
    <phone>+86 13883902288</phone>
    <email>yupeiwu1961@aliyun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Chuan, M.D</last_name>
    <phone>+86-18323479228</phone>
    <email>lee_tran@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yu Yupeiwu, M.D/Ph.D</last_name>
      <phone>+8618323479228</phone>
      <email>yupeiwu01@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 24, 2018</study_first_posted>
  <last_update_submitted>July 13, 2018</last_update_submitted>
  <last_update_submitted_qc>July 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Li Chuan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Robotic</keyword>
  <keyword>Intersphincteric Resection</keyword>
  <keyword>rectal cancer</keyword>
  <keyword>pelvic autonomic nerve anal function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

